Antibodies to the C-type lectin, L-SIGN, as tentative therapeutic agents for induction of antigen-specific tolerance

Author：

ISSN： 1354-3776

Source： Expert Opinion on Therapeutic Patents, Vol.17, Iss.2, 2007-02, pp. : 243-250

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Multivalent Compounds for Antigen-Specific B Cell Tolerance and Treatment of Autoimmune Diseases

Current Medicinal Chemistry, Vol. 12, Iss. 16, 2005-08 ,pp. : 1887-1904

Bentham Science Publishers

Access to resources Recommend Favorite

C-type Lectin Receptor: Old Friend and New Player

Medicinal Chemistry, Vol. 13, Iss. 6, 2017-08 ,pp. : 536-543

Bentham Science Publishers

Access to resources Recommend Favorite

C-type Natriuretic Peptide (CNP): Cardiovascular Roles and Potential as a Therapeutic Target

Current Pharmaceutical Design, Vol. 16, Iss. 37, 2010-12 ,pp. : 4080-4088

Bentham Science Publishers

Access to resources Recommend Favorite

In vitro antigen-specific induction of IL-22 in human subjects that resolved HCV infection

By Cusick Matthew F Libbey Jane E Fujinami Robert S Eckels David D

Future Virology, Vol. 7, Iss. 7, 2012-07 ,pp. : 719-728

Future Medicine

Access to resources Recommend Favorite

Editorial [Hot Topic: The Type XIV Family of C-type Lectin-like Domain (CTLD) Containing Proteins (Guest Editor: Edward M. Conway)]

Current Drug Targets, Vol. 13, Iss. 3, 2012-01 ,pp. : 409-410

Bentham Science Publishers

Access to resources Recommend Favorite